229 related articles for article (PubMed ID: 19759137)
21. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
Rockx B; Bossart KN; Feldmann F; Geisbert JB; Hickey AC; Brining D; Callison J; Safronetz D; Marzi A; Kercher L; Long D; Broder CC; Feldmann H; Geisbert TW
J Virol; 2010 Oct; 84(19):9831-9. PubMed ID: 20660198
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
[TBL] [Abstract][Full Text] [Related]
23. Animal Models for Henipavirus Research.
Pigeaud DD; Geisbert TW; Woolsey C
Viruses; 2023 Sep; 15(10):. PubMed ID: 37896758
[TBL] [Abstract][Full Text] [Related]
24. Hendra and Nipah infection: emerging paramyxoviruses.
Aljofan M
Virus Res; 2013 Nov; 177(2):119-26. PubMed ID: 23954578
[TBL] [Abstract][Full Text] [Related]
25. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.
Lo MK; Feldmann F; Gary JM; Jordan R; Bannister R; Cronin J; Patel NR; Klena JD; Nichol ST; Cihlar T; Zaki SR; Feldmann H; Spiropoulou CF; de Wit E
Sci Transl Med; 2019 May; 11(494):. PubMed ID: 31142680
[TBL] [Abstract][Full Text] [Related]
26. Transmission routes for nipah virus from Malaysia and Bangladesh.
Clayton BA; Middleton D; Bergfeld J; Haining J; Arkinstall R; Wang L; Marsh GA
Emerg Infect Dis; 2012 Dec; 18(12):1983-93. PubMed ID: 23171621
[TBL] [Abstract][Full Text] [Related]
27. The Nature of Exposure Drives Transmission of Nipah Viruses from Malaysia and Bangladesh in Ferrets.
Clayton BA; Middleton D; Arkinstall R; Frazer L; Wang LF; Marsh GA
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004775. PubMed ID: 27341030
[TBL] [Abstract][Full Text] [Related]
28. Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.
Satterfield BA; Cross RW; Fenton KA; Borisevich V; Agans KN; Deer DJ; Graber J; Basler CF; Geisbert TW; Mire CE
J Virol; 2016 Jul; 90(14):6326-6343. PubMed ID: 27147733
[TBL] [Abstract][Full Text] [Related]
29. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
[TBL] [Abstract][Full Text] [Related]
30. Recent developments in experimental animal models of Henipavirus infection.
Rockx B
Pathog Dis; 2014 Jul; 71(2):199-206. PubMed ID: 24488776
[TBL] [Abstract][Full Text] [Related]
31. Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains.
Leon AJ; Borisevich V; Boroumand N; Seymour R; Nusbaum R; Escaffre O; Xu L; Kelvin DJ; Rockx B
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006343. PubMed ID: 29538374
[TBL] [Abstract][Full Text] [Related]
32. The changing face of the henipaviruses.
Croser EL; Marsh GA
Vet Microbiol; 2013 Nov; 167(1-2):151-8. PubMed ID: 23993256
[TBL] [Abstract][Full Text] [Related]
33. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.
Bossart KN; Mungall BA; Crameri G; Wang LF; Eaton BT; Broder CC
Virol J; 2005 Jul; 2():57. PubMed ID: 16026621
[TBL] [Abstract][Full Text] [Related]
35. Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.
Zumbrun EE
Vet Pathol; 2015 Jan; 52(1):18-20. PubMed ID: 25352204
[TBL] [Abstract][Full Text] [Related]
36. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery.
Amaya M; Cheng H; Borisevich V; Navaratnarajah CK; Cattaneo R; Cooper L; Moore TW; Gaisina IN; Geisbert TW; Rong L; Broder CC
Antiviral Res; 2021 Sep; 193():105084. PubMed ID: 34077807
[TBL] [Abstract][Full Text] [Related]
37. Nipah virus: transmission of a zoonotic paramyxovirus.
Clayton BA
Curr Opin Virol; 2017 Feb; 22():97-104. PubMed ID: 28088124
[TBL] [Abstract][Full Text] [Related]
38. Emerging paramyxoviruses: molecular mechanisms and antiviral strategies.
Aguilar HC; Lee B
Expert Rev Mol Med; 2011 Feb; 13():e6. PubMed ID: 21345285
[TBL] [Abstract][Full Text] [Related]
39. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
40. Multi-step molecular docking and dynamics simulation-based screening of large antiviral specific chemical libraries for identification of Nipah virus glycoprotein inhibitors.
Kalbhor MS; Bhowmick S; Alanazi AM; Patil PC; Islam MA
Biophys Chem; 2021 Mar; 270():106537. PubMed ID: 33450550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
